ASEAN pharmaceutical manufacturing industry will grow by 12.8% annually with a total addressable market cap of $148.3 billion over 2021-2027 driven by increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic.
Highlighted with 25 tables and 39 figures, this 66-page report “ASEAN Pharmaceutical Manufacturing Market 2017-2027 by Formulation and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire ASEAN pharmaceutical manufacturing industry and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Industry Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Industry Opportunities
• Porter’s Fiver Forces
The trend and outlook of ASEAN industry is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify ASEAN pharmaceutical manufacturing industry in every aspect of the classification from perspectives of Formulation and Country.
Based on Formulation, the ASEAN industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
• Tablets
• Capsules
• Injectable
• Sprays
• Suspensions
• Powders
• Other Formulations
Geographically, the following national/local markets are fully investigated:
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Myanmar
• Cambodia
• Laos
• Brunei
For each key country, detailed analysis and data for annual production value are available for 2017-2027. The breakdown of key national industry by Formulation and Manufacturer is also included.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 6
1.2 Research Methodology 8
1.2.1 Overview of Market Research Methodology 8
1.2.2 Market Assumption 9
1.2.3 Secondary Data 9
1.2.4 Primary Data 9
1.2.5 Data Filtration and Model Design 11
1.2.6 Market Size/Share Estimation 12
1.2.7 Research Limitations 13
1.3 Executive Summary 14
2 Market Overview and Dynamics 16
2.1 Market Size and Forecast 16
2.1.1 Impact of COVID-19 on World Economy 17
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 25
2.4 Emerging Opportunities and Market Trends 28
2.5 Porter’s Fiver Forces Analysis 32
3 Segmentation of ASEAN Market by Formulation 36
3.1 Market Overview by Formulation 36
3.2 Tablets 38
3.3 Capsules 39
3.4 Injectable 40
3.5 Sprays 41
3.6 Other Formulations 42
4 ASEAN Market 2020-2027 by Country 43
4.1 Overview of ASEAN Market 43
4.2 Indonesia 46
4.3 Thailand 48
4.4 Philippines 50
4.5 Vietnam 52
4.6 Singapore 54
4.7 Malaysia 56
4.8 Myanmar 58
4.9 Cambodia 60
4.10 Laos 62
4.11 Brunei 64
Related Reports and Products 66
Table 1. Snapshot of ASEAN Pharmaceutical Manufacturing Market in Balanced Perspective, 2020-2027 15
Table 2. Growth Rate of World Real GDP, 2017-2021 18
Table 3. Main Product Trends and Market Opportunities in ASEAN Pharmaceutical Manufacturing Market 28
Table 4. ASEAN Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 36
Table 5. ASEAN region Pharmaceutical Manufacturing Market by Country, 2017-2027, $ bn 45
Table 6. Indonesia Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 47
Table 7. Indonesia Pharmaceutical Manufacturing Market by Company 47
Table 8. Thailand Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 49
Table 9. Thailand Pharmaceutical Manufacturing Market by Company 49
Table 10. Philippines Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 51
Table 11. Philippines Pharmaceutical Manufacturing Market by Company 51
Table 12. Vietnam Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 53
Table 13. Vietnam Pharmaceutical Manufacturing Market by Company 53
Table 14. Singapore Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 55
Table 15. Singapore Pharmaceutical Manufacturing Market by Company 55
Table 16. Malaysia Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 57
Table 17. Philippines Pharmaceutical Manufacturing Market by Company 57
Table 18. Myanmar Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 59
Table 19. Myanmar Pharmaceutical Manufacturing Market by Company 59
Table 20. Cambodia Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 61
Table 21. Cambodia Pharmaceutical Manufacturing Market by Company 61
Table 22. Laos Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 63
Table 23. Laos Pharmaceutical Manufacturing Market by Company 63
Table 24. Brunei Pharmaceutical Manufacturing Market by Formulation, 2017-2027, $ bn 65
Table 25. Brunei Pharmaceutical Manufacturing Market by Company 65
